- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mo | JPMorgan Keeps an Overweight Rating on Carvana Co. (CVNA) | ||
| Mo | Something Bigger Is Happening in Connectivity Markets - TE Connectivity (TEL) At $250 | ||
| Mo | Bitdeer Technologies Group (BTDR) Rating Lowered by Cantor Fitzgerald Amid Execution Concerns | ||
| Mo | ImmunityBio, Inc. (IBRX) Posts Strong Preliminary Q1 Sales on ANKTIVA Momentum | ||
| Mo | CleanSpark, Inc. (CLSK) Price Target Trimmed as Cantor Stays Bullish on AI Infrastructure | ||
| Mo | Lucid Group (LCID) Reports Q1 Deliveries Impacted by Temporary Supply Disruption | ||
| Mo | Analysts Hold Neutral Stance on Avantor, Inc. (AVTR) Amid Lower Valuation Expectations | ||
| Mo | Why Lumentum (LITE) Just Saw One of the Most Aggressive Target Revisions in Tech | ||
| Mo | 13 NASDAQ Stocks with Highest Dividends | ||
| Mo | Citi Lowered PT on Astera Labs (ALAB), Is It Still the Best Growth Stock? | ||
| Mo | Jim Cramer on Amazon (AMZN): "Jassy Put My Mind at Ease in Incredible Fashion" | ||
| Mo | Jim Cramer on Regeneron (REGN): "I Think The Stock's Breaking Out Here" | ||
| Mo | Jim Cramer on D-Wave (QBTS): "Maybe the Science Project Works Out, But It Is More of a Science Project" | ||
| Mo | Jim Cramer Bearish on Newsmax (NMAX) Because "They're Losing Money" | ||
| Mo | Jim Cramer on Qnity: "It's Probably the Most Undervalued of the Data Center Stocks Right Now" | ||
| Mo | Jim Cramer Says "I Think at 5.25% Yield, I Want to Own Kimberly-Clark (KMB)" | ||
| Mo | Jim Cramer on The Vita Coco Company (COCO): "I Think This Could Be a Nice Buying Opportunity" | ||
| Mo | Jim Cramer on Levi Strauss (LEVI): "This Stock Could Have Lots of Upside Ahead of It" | ||
| Mo | Jim Cramer on Reddit (RDDT): "The Stock Is Suffering, the Company's Not" | ||
| Mo | Jim Cramer on Abercrombie & Fitch (ANB): "I Think the Bounce Back Is Very for Real" | ||
| Mo | Wedbush Bullish on Nuvation Bio (NUVB) As NUVB Expands Safusidenib Rights | ||
| Mo | Genius Sports (GENI) Hits 52-Week Low Following 50% Year-to-Date Decline | ||
| Mo | Why Do Analysts See 180%+ Upside for Allogene Therapeutics (ALLO)? | ||
| Mo | Repay Holdings (RPAY) Scales Up in Bill Payments and Customer Interactions; Analysts See 170%+ Upside | ||
| Mo | Analysts Remain Bullish on Gossamer Bio (GOSS) Despite Phase 3 Setback |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.